{{ 'fb_in_app_browser_popup.desc' | translate }} {{ 'fb_in_app_browser_popup.copy_link' | translate }}
{{ 'in_app_browser_popup.desc' | translate }}
Suitable for 6 weeks old or above
(Individuals who have completed 3 or 4 doses of the 13-valent or 15-valent pneumonia vaccine can receive 1 dose of the 20-valent vaccine for added protection)
Not enough stock.
Your item was not added to your cart.
Not enough stock.
Please adjust your quantity.
{{'products.quick_cart.out_of_number_hint'| translate}}
{{'product.preorder_limit.hint'| translate}}
Limit {{ product.max_order_quantity }} per order.
Only {{ quantityOfStock }} item(s) left.
【20-valentPneumococcal Conjugate Vaccine (PCV20)】1 dose Suitable for 6 months old or above
Individuals who have completed 3 or 4 doses of the 13-valent or 15-valent pneumonia vaccine can receive 1 dose of the 20-valent vaccine for added protection
Vaccine details:Click here
Pneumococcal infection represents a wide range of diseases caused by the bacterium Streptococcus pneumoniae (or more commonly referred to as pneumococcus). While pneumococcus is a common cause of mild illnesses such as sinus or middle ear infections, it may also cause severe or even life-threatening invasive pneumococcal diseases (IPD) such as bacteremic pneumonia, sepsis, and meningitis. The outcomes for IPD are usually more severe among young children and elderly persons.
The Scientific Committee on Vaccine Preventable Diseases (SCVPD) recommends children under 2 years of age to receive pneumococcal conjugate vaccines (PCV) under the Hong Kong Childhood Immunisation Programme (HKCIP). The standard regimen includes a primary series of 3 doses at 2, 4 and 6 months and a booster dose at 12-15 months.